for hims glp 1 & Hers Stock Plummets. The Wegovy Shortage Is Over Hims & Hers tackles high
Description
doi: 10.1016/j.gie.2024.12.019

(15-19) Liraglutide was found to improve bone microarchitecture and restore bone mass in rats with diabetic osteoporosis, as evidenced by upregulation of Wnt/-catenin signaling and suppression of RANKL expression, leading to increased OPG and osteocalcin levels

Author Bio Julia Malkowski ND, DC, BSc Dr

Public Health Impact Clinical data shows semaglutide can achieve ~15% body-weight reduction, making it one of the most effective pharmacological treatments available for obesity management

However, it is still being studied and is not currently approved for routine medical use

Hypoglycaemia risk increases when GLP-1 agonists are combined with insulin or sulphonylureas, requiring careful medication review and dose adjustment
